{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T10:25:45Z","timestamp":1793787945934,"version":"4.6.1"},"reference-count":42,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Risk &amp; Safety in Medicine"],"published-print":{"date-parts":[[2026,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Stevens\u2013Johnson Syndrome (SJS) is a rare and severe drug-induced cutaneous reaction. However, clinical and economic data regarding its management remain poorly documented in Gabon. Therefore, this study aimed to describe the clinical characteristics, drug causality assessment, therapeutic management, and direct medical costs of four confirmed cases of SJS managed at the Libreville University Hospital Center (CHUL).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case report<\/jats:title>\n                    <jats:p>Four confirmed cases of SJS related respectively to lidocaine, allopurinol, amoxicillin\/clavulanic acid, and flucloxacillin were identified. Drug causality assessment, performed using the French causality assessment method, the World Health Organization (WHO) scale, and the ALDEN algorithm, indicated a probable causal relationship in all cases. SCORTEN scores ranged from 0 to 1, corresponding to an estimated mortality rate of 3.2%. Therapeutic management was based on symptomatic and supportive treatment, including Polaramine, Solumedrol, Dacryoserum, eosin solution, Fucithalmic, sodium bicarbonate, Fungizone, Dexeryl, ciprofloxacin, and Exomuc, with favorable clinical outcomes observed in all patients. The mean direct medical cost of management was estimated at 225,089 CFA francs (343.14 \u20ac), with a total cost of 860,355 CFA francs (1311.60 \u20ac) for the four cases.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SJS remains a severe dermatological emergency associated with substantial management costs despite favorable clinical outcomes. These findings highlight the importance of strengthening pharmacovigilance activities and the prevention of serious adverse drug reactions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/09246479261479445","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T18:48:54Z","timestamp":1787338134000},"page":"554-566","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Stevens\u2013Johnson Syndrome identified at the University Hospital Center of Libreville, Gabon: Four case reports"],"prefix":"10.1177","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-8330-7476","authenticated-orcid":false,"given":"Pierre Constant","family":"N Nzoghe","sequence":"first","affiliation":[{"name":"Mohammed V University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Landry","family":"Missounga","sequence":"additional","affiliation":[{"name":"University Hospital Center of Libreville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Coniquet","sequence":"additional","affiliation":[{"name":"University Hospital Center of Libreville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solange","family":"Ntsame","sequence":"additional","affiliation":[{"name":"University Hospital Center of Libreville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-8796-3837","authenticated-orcid":false,"given":"Rim","family":"Lakhmiri","sequence":"additional","affiliation":[{"name":"Mohammed V University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia","family":"Cherrah","sequence":"additional","affiliation":[{"name":"Mohammed V University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8599-7257","authenticated-orcid":false,"given":"Samira","family":"Serragui","sequence":"additional","affiliation":[{"name":"Mohammed V University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"e_1_3_4_2_2","unstructured":"Benedetti J McKoy K. MSD manuals for the general public: Stevens-johnson syndrome (SJS) and toxic epidermal necrolysis (TEN or lyell syndrome) \u2013 skin disorders. Available from. https:\/\/www.msdmanuals.com\/fr\/accueil\/troubles-cutan\u00e9s\/hypersensibilit\u00e9-et-troubles-cutan\u00e9s-inflammatoires\/syndrome-de-stevens-johnson-ssj-et-n\u00e9crolyse-\u00e9pidermique-toxique-net-ou-syndrome-de-lyell (2024) Accessed October 17 2025."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30378-6"},{"key":"e_1_3_4_4_2","first-page":"547","article-title":"Erythema multiforme, Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: diagnosis and treatment","volume":"18","author":"Gr\u00fcnwald P","year":"2020","unstructured":"Gr\u00fcnwald P, Mockenhaupt M, Panzer R, et al. Erythema multiforme, Stevens\u2013Johnson syndrome\/toxic epidermal necrolysis: diagnosis and treatment. J Dtsch Dermatol Ges 2020; 18: 547\u2013553. https:\/\/doi.org\/10.1111\/ddg.14118","journal-title":"J Dtsch Dermatol Ges"},{"issue":"3","key":"e_1_3_4_5_2","first-page":"52","article-title":"Clinical characteristics, outcomes, and management of drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children","volume":"90","author":"Liotti L","year":"2019","unstructured":"Liotti L, Caimmi S, Bottau P. Clinical characteristics, outcomes, and management of drug-induced Stevens\u2013Johnson syndrome and toxic epidermal necrolysis in children. Acta Biomed 2019; 90(3-S): 52\u201360.","journal-title":"Acta Biomed"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1097\/PEC.0000000000000840"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.03.023"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1177\/2040622319894469"},{"issue":"6","key":"e_1_3_4_9_2","first-page":"475","article-title":"Advances in the understanding of the pathophysiology of epidermal necrolysis","volume":"147","author":"Lalev\u00e9e S","year":"2020","unstructured":"Lalev\u00e9e S, Contassot E, Ortonne N, et al. Advances in the understanding of the pathophysiology of epidermal necrolysis. Ann Dermatol Venereol 2020; 147(6): 475\u2013481. https:\/\/doi.org\/10.1016\/j.annder.2020.02.010","journal-title":"Ann Dermatol Venereol"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.3390\/medicina57090895"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.03.023"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40629-019-00111-8"},{"issue":"2","key":"e_1_3_4_13_2","first-page":"116","article-title":"Lyell syndrome and Stevens-Johnson syndrome: retrospective study of 30 cases","volume":"35","author":"Hamish S","year":"2022","unstructured":"Hamish S, Houssaini AS, Ismaili N. Lyell syndrome and Stevens-Johnson syndrome: retrospective study of 30 cases. Ann Burns Fire Dis 2022; 35(2): 116\u2013124.","journal-title":"Ann Burns Fire Dis"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.5415\/apallergy.2022.12.e17"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1775888"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14409"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.reval.2017.06.002"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-74588-6_195"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11010177"},{"key":"e_1_3_4_20_2","unstructured":"Ghada MS H\u00e9l\u00e8ne T Fran\u00e7oise H et al. Accountability in pharmacovigilance: from the French method to updated methods. 2016;71:171\u2013178."},{"issue":"2","key":"e_1_3_4_21_2","first-page":"96","article-title":"Stevens\u2013Johnson syndrome following cataract surgery","volume":"5","author":"Wu S-H","year":"2015","unstructured":"Wu S-H, Shen J-H, Hsu W-H, et al. Stevens\u2013Johnson syndrome following cataract surgery. Stevens-Johnson Syn Cataract Surg 2015; 5(2): 96\u201398. https:\/\/doi.org\/10.1016\/j.tjo.2014.05.005","journal-title":"Stevens-Johnson Syn Cataract Surg"},{"key":"e_1_3_4_22_2","first-page":"348","article-title":"Allopurinol-induced Stevens-Johnson syndrome","volume":"357","author":"Gupta SS","year":"2019","unstructured":"Gupta SS, Nitin S, Patti R. Allopurinol-induced Stevens-Johnson syndrome. J Clin Pharm 2019; 357: 348\u2013351.","journal-title":"J Clin Pharm"},{"key":"e_1_3_4_23_2","first-page":"99","article-title":"Allopurinol-induced Stevens-Johnson syndrome","volume":"15","author":"Takla RA","year":"2013","unstructured":"Takla RA, Meher J. Allopurinol-induced Stevens-Johnson syndrome. Clin Pharmacol 2013; 15: 99\u2013105.","journal-title":"Clin Pharmacol"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.22270\/jddt.v10i4-s.4205"},{"key":"e_1_3_4_25_2","first-page":"748","article-title":"Amoxicillin\u2013clavulanic acid-induced Stevens-Johnson syndrome: a case report","volume":"16","author":"Zaidi M","year":"2017","unstructured":"Zaidi M, Zaidi SK, Bhutto M. Amoxicillin\u2013clavulanic acid-induced Stevens-Johnson syndrome: a case report. ECLI J 2017; 16: 748\u2013751. https:\/\/doi.org\/10.17179\/excli2017-345","journal-title":"ECLI J"},{"key":"e_1_3_4_26_2","volume-title":"Monitoring the safety of medicines","author":"World Health Organization","year":"2000","unstructured":"World Health Organization. Monitoring the safety of medicines. World Health Organization, 2000."},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2009.252"},{"key":"e_1_3_4_28_2","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie. ALDEN score. Available from. https:\/\/www.sfdermato.org\/upload\/groupe\/bloc\/file\/score-alden-pdf.pdf"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00061.x"},{"key":"e_1_3_4_30_2","unstructured":"Soci\u00e9t\u00e9 Fran\u00e7aise de Dermatologie. SCORTEN guidelines. Available from. https:\/\/www.sfdermato.org\/upload\/recommandations\/ald-31-pnds-sjs-lyell-web.pdf"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.2332\/allergolint.55.9"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2011.1314"},{"key":"e_1_3_4_33_2","first-page":"27","volume-title":"Textbook of adverse drug reactions","author":"Rawlins MD","year":"1977","unstructured":"Rawlins MD, Thompson JW. Pathogenesis of adverse drug reactions. In: Davies DM (ed). Textbook of adverse drug reactions. 10th. Oxford University Press, 1977, p. 27.","edition":"10"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-018-0793-7"},{"issue":"7","key":"e_1_3_4_35_2","first-page":"917","article-title":"Epidermal necrolysis (Stevens\u2013Johnson syndrome and lyell syndrome): clinical manifestations and management","volume":"207","author":"Ingen-Housz-Oro S","year":"2023","unstructured":"Ingen-Housz-Oro S. Epidermal necrolysis (Stevens\u2013Johnson syndrome and lyell syndrome): clinical manifestations and management. Bull Acad Natl Med 2023; 207(7): 917\u2013923.","journal-title":"Bull Acad Natl Med"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.05.020"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S378106"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2026.100962"},{"key":"e_1_3_4_39_2","first-page":"44","article-title":"55 Risk of sepsis and mortality in SJS and TENS patients treated with corticosteroids","volume":"15","author":"Everett C","year":"2023","unstructured":"Everett C, Hink A, Kahn S. 55 Risk of sepsis and mortality in SJS and TENS patients treated with corticosteroids. J Burn Care Res 2023; 15: 44.","journal-title":"J Burn Care Res"},{"key":"e_1_3_4_40_2","unstructured":"Africabizinfo. Office pharmaceutique national (OPN). Available from. https:\/\/www.africabizinfo.com\/GA\/office-pharmaceutique-national-opn-04-35-79-29 Accessed October 30 2023."},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.5334\/gh.1535"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph22101488"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12913-021-07260-z"}],"container-title":["International Journal of Risk &amp; Safety in Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09246479261479445","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/09246479261479445","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/09246479261479445","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T09:38:03Z","timestamp":1793785083000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/09246479261479445"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":42,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1177\/09246479261479445"],"URL":"https:\/\/doi.org\/10.1177\/09246479261479445","relation":{"has-review":[{"id-type":"doi","id":"10.1177\/09246479261479445\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v4\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v4\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v3\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v4\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v3\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v3\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1177\/09246479261479445\/v1\/review1","asserted-by":"object"}]},"ISSN":["0924-6479","1878-6847"],"issn-type":[{"value":"0924-6479","type":"print"},{"value":"1878-6847","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]}}}